SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Isolyser (OREX)- Any comments
OREX 0.223-34.4%Apr 3 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W. Kent Ward who wrote (267)2/13/1997 8:49:00 AM
From: Fenton White   of 617
 
Kent:
I have been watching OREX for several months and I wonder if anyone has any idea as to the size of the charge for 4Q. I noticed that they took a charge for 3Q and I wonder how much is left to write down? If they end up with a .03 or .04 loss before charge I would be happy. The stock is adjusted for that consideration and I think that analysis of the core business will probably be positive.. We have reduced our targets for the year and still believe the 6 month target of 12 to 15 is well within range given the clearing of the slate that they are planning for 4Q.

We are expanding our positions in this stock for a 6 month to 1 year hold.

We consider this stock a strong buy, they have plenty of cash and the book value is near 5.00..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext